Pharmaceutical company AstraZeneca will join EV100, The Climate Group’s business initiative on electric vehicles. Through the initiative, AstraZeneca pledges to transition its fleet of 16,000 vehicles to EVs.
AstraZeneca is the 50th business and first global healthcare company to join EV100, which now includes companies representing $900 billion in annual turnover and 2.8 million employees, according to The Climate Group. AstraZeneca expects its switch to EVs to displace 80,000 metric tons of CO2 annually beginning in 2030.
Helen Clarkson, The Climate Group CEO, said, “When a pharmaceutical company says we need to go electric to help everyone breathe clean air, every business with a fleet needs to listen. This is great example of a company addressing the global climate and air pollution crisis.”
Katarina Ageborg, AstraZeneca’s EVP of Sustainability and Chief Compliance Officer, said, “Recognizing the link between a healthy environment and human health, we believe that by investing in electric vehicles and emissions-reduction initiatives, we can help reduce the burden of respiratory diseases and other air pollution-related conditions.”
Source: The Climate Group